Literature DB >> 1350086

[Multiple cholesterol embolism mimicking periarteritis nodosa].

J Cosserat1, O Bletry, C Frances, B Wechsler, J C Piette, E Kieffer, G Chomette, P Godeau.   

Abstract

Ten men aged 56 to 84 were hospitalized with a diagnosis of periarteritis nodosa, whereas they had multiple cholesterol embolism. The diagnosis was corrected post mortem in the first 3 patients and subsequently in live patients. The particularly misleading clinical manifestations were neurological (polyneuritis in 5 cases, mononeuritis in 1, central nervous system disorders in 3), pulmonary (alveolar haemorrhage in 2 cases, respiratory failure of unknown mechanism in 4) and pericardial (2 cases). Five patients had eosinophilia (more than 500 eosinophils/mm3). The elements that led to the correct diagnosis were the presence of vascular risk factors in all 10 patients (but hyperlipidaemia in only one), severe complications of the atheromatous disease in all cases, a precipitating or aggravating factor in 8 patients (anticoagulant therapy in 7, arteriography in 6) and the finding of purple or necrotic toes (6 cases). Histological (5 cases) and/or ophthalmological (2 cases) evidence was obtained in only 6 patients. Seven patients died 1 to 3 years after the onset of the disorders. Studies on low-density lipoprotein metabolism are in progress to determine the mechanism of clinical manifestations unexplainable by embolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350086

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  Can arterial catheterisation induce autoimmune disease?

Authors:  R M Cabral Susano; L C Montero; F A Fierro; J M Mosquera
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

2.  Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases.

Authors:  A E Yücel; H Kart-Köseoglu; B Demirhan; F N Ozdemir
Journal:  Rheumatol Int       Date:  2005-07-16       Impact factor: 2.631

Review 3.  Cholesterol embolisation after thrombolytic therapy.

Authors:  J C Blankenship
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.